Heterogeneity in statin responses explained by variation in the human gut microbiome
Prior work has indicated that stain therapy impacts gut microbiome composition and that gut bacteria can metabolize statins, but the clinical implications of these interactions remain unknown. Wilmanski et al. identify robust associations between microbiome composition and on-target and adverse responses to statins, which could prove useful in drug personalization.
Read the full article: "Heterogeneity in statin responses explained by variation in the human gut microbiome” by Dr Wilmanski and colleagues: https://www.cell.com/med/fulltext/S26...
Video: Tomasz Wilmanski, PhD
Institute for Systems Biology, Seattle, WA, USA
Watch video Heterogeneity in statin responses explained by variation in the human gut microbiome online without registration, duration hours minute second in high quality. This video was added by user Cell Press 27 May 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 423 once and liked it 9 people.